We are live on
!
Find out more
GF
Gray Foundation Portfolio holdings
AUM
$454M
1-Year Est. Return
38.19%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+38.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$399M
AUM Growth
+$47.2M
(+13%)
Cap. Flow
+$14.1M
Cap. Flow
% of AUM
3.54%
Top 10 Holdings %
Top 10 Hldgs %
99.16%
Holding
11
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neurocrine Biosciences
NBIX
|
+$5.48M |
| 2 |
Boeing
BA
|
+$5.43M |
| 3 |
AstraZeneca
AZN
|
+$3.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 55.12% |
| 2 | Communication Services | 8.82% |
| 3 | Real Estate | 2.38% |
| 4 | Healthcare | 2.19% |
| 5 | Industrials | 1.44% |
Similar funds
WCM
IIA
BWA
MI
GA
PIM
IP
ACM
Gray Foundation's Q4 2025 Portfolio in Review
As of Q4 2025, Gray Foundation held 11 positions worth $399M, up 13% from $351M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Gray Foundation deployed $14.1M of net new capital in Q4 2025, opening 3 new positions. Its largest new stake was Neurocrine Biosciences: 37,800 shares worth $5.36M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 55% of assets, down from 57% a quarter earlier, followed by Communication Services and Real Estate.
- Gray Foundation's largest Q4 2025 buy was Neurocrine Biosciences: 37,800 shares worth $5.36M.
- Gray Foundation's ten largest holdings make up 99% of its $399M portfolio in Q4 2025.
- Gray Foundation opened 3 new positions and closed 0 in Q4 2025.
- Gray Foundation's portfolio value rose 13% quarter-over-quarter to $399M.
Based on Gray Foundation's 13F filing for Q4 2025, filed 29 Jan 2026.